The organisation of health care and epidemiology of multiple sclerosis in France;Données épidémiologiques et analyse de l'offre de soins de la sclérose en plaques en France

Revue Neurologique

Volumn 163, Issue 6-7, 2007, Pages 637-645

  Debouverie, M ^a,b   Rumbach, L ^c   Clavelou, P ^d  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Epidemiology; Ethnic role; Incidence; Multiple sclerosis; North African; Prevalence

Indexed keywords

AGE DISTRIBUTION; CLINICAL FEATURE; CONFERENCE PAPER; COURSE EVALUATION; EXPANDED DISABILITY STATUS SCALE; FRANCE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MEDICAL CARE; MULTIPLE SCLEROSIS; NATIONAL HEALTH INSURANCE; PREVALENCE; SCORING SYSTEM; SEX RATIO;

EID: 34347326930     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90472-5     Document Type: Conference Paper

References (34)

1. ALPEROVITCH A, BOUVIER MH. (1982). Geographical pattern of death rates from multiple sclerosis in France. An analysis of 4912 deaths. Acta Neurol Scand, 66: 454-461.
2. BERR C, PUEL J, CLANET M, RUIDAVETS JB, MAS JL, ALPEROVITCH A. (1989). Risk factors in multiple sclerosis: a population-based case-control study in Hautes- Pyrénées, France. Acta Neurol Scand, 80: 46-50.
3. CABRE P, SIGNATE A, OLINDO S et al. (2005). Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain, 128: 2899-2910.
4. CONFAVREUX C, DARCY B, ALPEROVITCH A, AIMARD G, DEVIC M. (1987). Le Sud-Est français, zone à haut risque de SEP ? Presse Med, 16 : 622-623.
5. CONFAVREUX C, COMPSTON DA, HOMMES OR, MCDONALD WI, THOMPSON AJ. (1992). EDMUS, an European database for multiple sclerosis. J Neurol Neurosurg Psychiatry, 55: 671-676.
6. CREE BA, KHAN O, BOURDETTE D et al. (2004). Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology, 63: 2039-2045.
7. DAHL OP, AARSETH JH, MYHR KM, NYLAND H, MIDGARD R. (2004). Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. Acta Neurol Scand, 109: 378-384.
8. DEBOUVERIE M, LEBRUN C, JEANNIN S, PITTION-VOUYOVITCH S, ROEDERER T, VESPIGNANI H. (2007a). More severe disability of North Africans vs Europeans with multiple sclerosis in France. Neurology, 68: 29-32.
9. DEBOUVERIE M, PITTION-VOUYOVITCH S, LOUIS S, ROEDERER L, GUILLEMIN F. (2007b). Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler in press.
10. DELASNERIE-LAUPRETRE N, ALPEROVITCH A. (1991). L'épidémiologie de la Sclérose en plaques. Rev Prat, 41 : 1884-1887.
11. ESBJERG S, KEIDING N, KOCH-HENRIKSEN N. (1999). Reporting delay and corrected incidence of multiple sclerosis. Stat Med, 18: 1691-1706.
12. FENDER P, PAITA M, GANAY D et al. (1997). Prévalence des trente affections de longue durée pour les affiliés au Régime Général de l'Assurance Maladie en 1994. Rev Epidém et Santé Publ, 45 : 454-464.
13. GALLOU M, MADIGAND M, MASSE L, MOREL G, OGER J, SABOURAUD O. (1983). Épidémiologie de la sclérose en plaques en Bretagne. Presse Med, 12 : 995-999.
14. GRANIERI E, CASETTA I, GOVONI V et al. (2000). The increasing incidence and prevalence of MS in a Sardinian province. Neurology, 55: 842-8.
15. GRAY OM, MCDONNELL GV, HAWKINS SA. (2006). The epidemiology of multiple sclerosis in the northeast region of Northern Ireland - A high and rising prevalence. Mult Scler, 12 (suppl 1): S125, P454.
16. GRYTTEN N, GLAD SB, AARSETH JH, NYLAND H, MIDGARD R, MYHR KM. (2006). A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology, 66: 182-186.
17. KOCH-HENRIKSEN N, STENAGER E, BRONNUM-HANSEN, FLACHS EM. (2006). Increasing incidence of multiple sclerosis in Danish women. Mult Scler, 12 (suppl 1): S125, P453.
18. KURTZKE JF. (1980). Geographic distribution of multiple sclerosis: an update with special reference to Europe and the Mediterranean region. Acta Neurol Scand, 62: 65-80.
19. LHERMITTE F, ALPEROVITCH A, LYON-CAEN O. (1988). Enquête sur la sclérose en plaques lancée par la télévision Française. Rev Neurol (Paris), 144 : 135-136.
20. MARRIE RA, CUTTER G, TYRY T, HADJIMICHAEL O, CAMPAGNOLO D, VOLLMER T. (2005). Changes in the ascertainment of multiple sclerosis. Neurology, 65: 1066-1070.
21. MOREAU T, MANCEAU E, LUCAS B, LEMESLE M, URBINELLI R, GIROUD M. (2000). Incidence of multiple sclerosis in Dijon. Neurol Res, 22: 156-159.
22. NICOLETTI A, PATTI F, LO FERMO S et al. (2005). Possible increasing risk of multiple sclerosis in Catania, Sicily. Neurology, 65: 1259-1263.
23. PITTOCK SJ, MAYR WT, MCCLELLAND RL et al. (2004). Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology, 62: 601-606.
24. POSER CM, PATY DW, SCHEINBERG L et al. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol, 13: 227-31.
25. POZZILLI C, BRUNETTI M, AMICOSANTE AM et al. (2002). Home based management in multiple sclerosis: results of a randomised controlled trial. J Neurol Neurosurg Psychiatry, 73: 250-255.
26. PUGLIATTI M, SOTGIU S, SOLINAS G et al. (2001). Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand, 103: 20-26.
27. PUGLIATTI M, RIISE T, SOTGIU MA et al. (2005). Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology, 25: 129-134.
28. SARASOJA T, WIKSTROM J, PALTAMAA J, HAKAMA M, SUMELAHTI ML. (2004). Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand, 110: 331-336.
29. SUMELAHTI ML, TIENARI PJ, HAKAMA M, WIKSTROM J. (2003). Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses. J Neurol Neurosurg Psychiatry, 74: 25-28.
30. SUNDSTROM P, NYSTROM L, FORSGREN L. (2003). Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J Neurol Neurosurg Psychiatry, 74: 29-32.
31. TAITHE F, TILIGNAC C, RIEU L, MURAT C, CLAVELOU P ON BEHALF RESEAU SEP AUVERGNE. (2006). Incidence of multiple sclerosis in Auvergne (French County): a population-based study. Mult Scler, 12 (suppl. 1): P478: S132-S137.
32. VUKUSIC S, VAN BOCKSTAEL V, GOSSELIN S, CONFAVREUX C. (2007). J Neurol Neurosurg Psychiatry 2007 13; [Epub ahead of print].
33. WEILL A, FENDER P, VALLIER N et al. (2005). Multiple sclerosis in France: incidence of the disease and prevalence on the treated patients. A study for the Public Health Fund. Mult Scler, 11(suppl. 1): P414; S107.
34. YAOUANG J, TRON I, LERAY E et al. (2005). Incidence of multiple sclerosis in Western France, 2000-2001. Mult Scler, 11 (suppl. 1): P411; S106.